Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Stockholders' Equity (Deficit)

v3.25.0.1
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Treasury Stock [Member]
Accumulated Deficit [Member]
Beginning balance at Nov. 30, 2022 $ (1,524,302) $ 148,480 $ 42,597,380 $ (22,632,649) $ (21,637,513)
Beginning balance, shares at Nov. 30, 2022   14,848,001      
Exercise of stock options (2,864) $ 12 (2,876)    
Exercise of stock options, shares   1,245      
Compensatory element of stock options 816,639   816,639    
Treasury stock (799,036)     (799,036)  
Net Income (Loss) (9,521,669)       (9,521,669)
Ending balance at Nov. 30, 2023 (11,031,232) $ 148,492 43,411,143 (23,431,685) (31,159,182)
Ending balance, shares at Nov. 30, 2023   14,849,246      
Exercise of stock options 76,402 $ 204 76,198    
Exercise of stock options, shares   20,373      
Compensatory element of stock options 781,128   781,128    
Treasury stock (1,423,871)     (1,423,871)  
Dividends declared ($0.90 per share) (2,020,539)       (2,020,539)
Net Income (Loss) 402,095       402,095
Ending balance at Nov. 30, 2024 $ (13,216,017) $ 148,696 $ 44,268,469 $ (24,855,556) $ (32,777,626)
Ending balance, shares at Nov. 30, 2024   14,869,619